Aleksa Milošević scouting report: 18 Superliga games at 19 and the two ends of a short contract

Aleksa Milošević scouting report: 18 Superliga games at 19 and the two ends of a short contract
Yazı Özetini Göster

Aleksa Milošević
Centre-Back / Right-Back
MevkiCentre-Back / Right-Back
KulüpMladost Lučani
UyrukSerbia
Yaş19
Doğum08.01.2007
Boy1.83 m
AyakRight
Piyasa Değeri€300K
Sözleşme30.06.2026 (renewal unconfirmed) ⚠
RolDeveloping Centre-Back

63/100
GP SCORE18 Superliga games at 19 in a first professional season with just 2 yellows is a real early signal; the short contract record adds both opportunity and uncertainty.

Overview

Aleksa Milošević, born 8 January 2007 in Kraljevo, is a 1.83 m right-footed centre-back. 2025-26 was his first professional season and he played 18 Superliga games directly — meaningful load for a 19-year-old defender — with only 2 yellows. One Serbia U18 cap.

Profile notes: modest height for the position, with a right-back secondary role suggesting mobility. No pre-season career record exists in sources. Structural note: the contract reads 30.06.2026 — a final-year look at 19. Unconfirmed renewal defines a low-cost young-defender window.

Data and Assessment

2025-26 Superliga
İstatistikDeğerPersentil
Apps18—
Yellows2—
U18 caps1—
Soccerway/TM; minutes split not found.
Strengths Development Areas
18 top-flight games at 19 — early trust 1.83 m — borderline for a centre-back
On the U18 radar A single-season career record
A short contract = a low-cost window The same short contract = uncertainty

Verdict

GP VERDICTWATCH

The age-minutes-discipline trio is a real early signal; a one-season sample is not enough to decide, but the contract state can accelerate the file.

A confirmed short contract plus regular 2026-27 minutes make a low-fee young-stock move logical.

FAQ

Who is Aleksa Milošević?

A centre-back born 8 January 2007 in Kraljevo; played 18 Superliga games in his first professional season.

Sources

GEGEN SCORE blends technical (20%), tactical (20%), mental (20%), physical (15%), potential (15%) and risk (10%, inverse-weighted) components into one editorial rating; it is a comparison tool, not a transfer decision by itself. Bio data verified against independent open sources. Last updated: 27 July 2026.

Bir Yorum Yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir

Benzer Yazılar